Early secreted antigenic target of 6-kDa protein of Mycobacterium tuberculosis primes dendritic cells to stimulate Th17 and inhibit Th1 immune responses

Journal of Immunology

Volumn 189, Issue 6, 2012, Pages 3092-3103

  Wang, Xisheng ^a   Barnes, Peter F ^a,b   Huang, Fangfang ^a   Alvarez, Ivana B ^a,e   Neuenschwander, Pierre F ^a   Sherman, David R ^c,d   Samten, Buka ^a  

^a UNIVERSITY OF TEXAS HEALTH CENTER   (United States)

^b University of Texas Health Science Center   (United States)

^c SEATTLE BIOMEDICAL RESEARCH INSTITUTE   (United States)

^d UNIVERSITY OF WASHINGTON   (United States)

^e UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 2; B7 ANTIGEN; CD40 LIGAND; CD86 ANTIGEN; CYCLIC AMP; EARLY SECRETORY ANTIGENIC TARGET 6; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HLA DR ANTIGEN; INTERFERON REGULATORY FACTOR 1; INTERLEUKIN 12P35; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 23; INTERLEUKIN 23P19; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN C JUN; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL INTERACTION; CELL MATURATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; HUMAN; HUMAN CELL; IMMUNOMODULATION; IMMUNOREGULATION; INTERFERON PRODUCTION; LYMPHOCYTE ACTIVATION; LYMPHOCYTE PROLIFERATION; MONOCYTE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS INHIBITION; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH17 CELL; TRANSCRIPTION REGULATION; UPREGULATION;

ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; CELLS, CULTURED; DENDRITIC CELLS; DOWN-REGULATION; HUMANS; MYCOBACTERIUM TUBERCULOSIS; TH1 CELLS; TH17 CELLS; UP-REGULATION;

EID: 84866182046     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1200573     Document Type: Article

References (75)

1. World Health Organization. 2010. Multidrug and Extensively Drug-Resistant TB (M/XDR-TB): 2010 Global Report on Surveillance and Response. WHO Press, Geneva, Switzerland.
2. Colditz, G. A., T. F. Brewer, C. S. Berkey, M. E. Wilson, E. Burdick, H. V. Fineberg, and F. Mosteller. 1994. Efficacy of BCG vaccine in the prevention of tuberculosis: meta-analysis of the published literature. JAMA 271: 698-702. (Pubitemid 24061706)
3. Sterne, J. A., L. C. Rodrigues, and I. N. Guedes. 1998. Does the efficacy of BCG decline with time since vaccination? Int. J. Tuberc. Lung Dis. 2: 200-207. (Pubitemid 28123518)
4. Andersen, P., A. B. Andersen, A. L. Sørensen, and S. Nagai. 1995. Recall of long-lived immunity to Mycobacterium tuberculosis infection in mice. J. Immunol. 154: 3359-3372.
5. Sørensen, A. L., S. Nagai, G. Houen, P. Andersen, and A. B. Andersen. 1995. Purification and characterization of a low-molecular-mass T-cell antigen secreted by Mycobacterium tuberculosis. Infect. Immun. 63: 1710-1717.
6. Langermans, J. A., T. M. Doherty, R. A. Vervenne, T. van der Laan, K. Lyashchenko, R. Greenwald, E. M. Agger, C. Aagaard, H. Weiler, D. van Soolingen, et al. 2005. Protection of macaques against Mycobacterium tuberculosis infection by a subunit vaccine based on a fusion protein of antigen 85B and ESAT-6. Vaccine 23: 2740-2750. (Pubitemid 40381267)
7. Dietrich, J., R. Billeskov, T. M. Doherty, and P. Andersen. 2007. Synergistic effect of bacillus Calmette Guerin and a tuberculosis subunit vaccine in cationic liposomes: increased immunogenicity and protection. J. Immunol. 178: 3721-3730. (Pubitemid 46417640)
8. Pym, A. S., P.Brodin, L.Majlessi,R.Brosch, C. Demangel,A.Williams,K.E. Griffiths, G. Marchal, C. Leclerc, and S. T. Cole. 2003. Recombinant BCG exporting ESAT-6 confers enhanced protection against tuberculosis. Nat. Med. 9: 533-539. (Pubitemid 36597098)
9. Olsen, A. W., A. Williams, L. M. Okkels, G. Hatch, and P. Andersen. 2004. Protective effect of a tuberculosis subunit vaccine based on a fusion of antigen 85B and ESAT-6 in the aerosol guinea pig model. Infect. Immun. 72: 6148-6150. (Pubitemid 39303732)
10. Aagaard, C., T. Hoang, J. Dietrich, P. J. Cardona, A. Izzo, G. Dolganov, G. K. Schoolnik, J. P. Cassidy, R. Billeskov, and P. Andersen. 2011. A multistage tuberculosis vaccine that confers efficient protection before and after exposure. Nat. Med. 17: 189-194.
11. Andersen, P. 2007. Tuberculosis vaccines: an update. Nat. Rev. Microbiol. 5: 484-487.
12. Cole, S. T., R. Brosch, J. Parkhill, T. Garnier, C. Churcher, D. Harris, S. V. Gordon, K. Eiglmeier, S. Gas, C. E. Barry, III, et al. 1998. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 393: 537-544. (Pubitemid 28319235)
13. Harboe, M., T. Oettinger, H. G. Wiker, I. Rosenkrands, and P. Andersen. 1996. Evidence for occurrence of the ESAT-6 protein in Mycobacterium tuberculosis and virulent Mycobacterium bovis and for its absence in Mycobacterium bovis BCG. Infect. Immun. 64: 16-22. (Pubitemid 26009335)
14. Hsu, T., S. M. Hingley-Wilson, B. Chen, M. Chen, A. Z. Dai, P. M. Morin, C. B. Marks, J. Padiyar, C. Goulding, M. Gingery, et al. 2003. The primary mechanism of attenuation of bacillus Calmette-Guérin is a loss of secreted lytic function required for invasion of lung interstitial tissue. Proc. Natl. Acad. Sci. USA 100: 12420-12425. (Pubitemid 37271575)
15. Gao, L. Y., S. Guo, B. McLaughlin, H. Morisaki, J. N. Engel, and E. J. Brown. 2004. A mycobacterial virulence gene cluster extending RD1 is required for cytolysis, bacterial spreading and ESAT-6 secretion. Mol. Microbiol. 53: 1677-1693.
16. van der Wel, N., D. Hava, D. Houben, D. Fluitsma, M. van Zon, J. Pierson, M. Brenner, and P. J. Peters. 2007. M. tuberculosis and M. leprae translocate from the phagolysosome to the cytosol in myeloid cells. Cell 129: 1287-1298.
17. de Jonge, M. I., G. Pehau-Arnaudet, M. M. Fretz, F. Romain, D. Bottai, P. Brodin, N. Honoré, G. Marchal, W. Jiskoot, P. England, et al. 2007. ESAT-6 from Mycobacterium tuberculosis dissociates from its putative chaperone CFP-10 under acidic conditions and exhibits membrane-lysing activity. J. Bacteriol. 189: 6028-6034.
18. Wang, X., P. F. Barnes, K. M. Dobos-Elder, J. C. Townsend, Y. T. Chung, H. Shams, S. E. Weis, and B. Samten. 2009. ESAT-6 inhibits production of IFN-γ by Mycobacterium tuberculosis-responsive human T cells. J. Immunol. 182: 3668-3677.
19. Peng, H., X. Wang, P. F. Barnes, H. Tang, J. C. Townsend, and B. Samten. 2011. The Mycobacterium tuberculosis early secreted antigenic target of 6 kDa inhibits T cell interferon-g production through the p38 mitogen-activated protein kinase pathway. J. Biol. Chem. 286: 24508-24518.
20. McCullough, K. C., N. Ruggli, and A. Summerfield. 2009. Dendritic cells - at the front-line of pathogen attack. Vet. Immunol. Immunopathol. 128: 7-15.
21. Lyakh, L., G. Trinchieri, L. Provezza, G. Carra, and F. Gerosa. 2008. Regulation of interleukin-12/interleukin-23 production and the T-helper 17 response in humans. Immunol. Rev. 226: 112-131.
22. Flynn, J. L., J. Chan, K. J. Triebold, D. K. Dalton, T. A. Stewart, and B. R. Bloom. 1993. An essential role for interferon γ in resistance to Mycobacterium tuberculosis infection. J. Exp. Med. 178: 2249-2254. (Pubitemid 23344886)
23. Cooper, A. M., D. K. Dalton, T. A. Stewart, J. P. Griffin, D. G. Russell, and I. M. Orme. 1993. Disseminated tuberculosis in interferon γ gene-disrupted mice. J. Exp. Med. 178: 2243-2247. (Pubitemid 23344885)
24. Ottenhoff, T. H., D. Kumararatne, and J. L. Casanova. 1998. Novel human immunodeficiencies reveal the essential role of type-I cytokines in immunity to intracellular bacteria. Immunol. Today 19: 491-494. (Pubitemid 28518024)
25. Fortin, A., L. Abel, J. L. Casanova, and P. Gros. 2007. Host genetics of mycobacterial diseases in mice and men: forward genetic studies of BCG-osis and tuberculosis. Annu. Rev. Genomics Hum. Genet. 8: 163-192.
26. van de Vosse, E., J. T. van Dissel, and T. H. Ottenhoff. 2009. Genetic deficiencies of innate immune signalling in human infectious disease. Lancet Infect. Dis. 9: 688-698.
27. Khader, S. A., J. E. Pearl, K. Sakamoto, L. Gilmartin, G. K. Bell, D. M. Jelley-Gibbs, N. Ghilardi, F. deSauvage, and A. M. Cooper. 2005. IL-23 compensates for the absence of IL-12p70 and is essential for the IL-17 response during tuberculosis but is dispensable for protection and antigen-specific IFN-γ responses if IL-12p70 is available. J. Immunol. 175: 788-795. (Pubitemid 41094960)
28. Okamoto Yoshida, Y., M. Umemura, A. Yahagi, R. L. O'Brien, K. Ikuta, K. Kishihara, H. Hara, S. Nakae, Y. Iwakura, and G. Matsuzaki. 2010. Essential role of IL-17A in the formation of a mycobacterial infection-induced granuloma in the lung. J. Immunol. 184: 4414-4422.
29. + T cell responses after vaccination and during Mycobacterium tuberculosis challenge. Nat. Immunol. 8: 369-377.
30. Cruz, A., A. G. Fraga, J. J. Fountain, J. Rangel-Moreno, E. Torrado, M. Saraiva, D. R. Pereira, T. D. Randall, J. Pedrosa, A. M. Cooper, and A. G. Castro. 2010. Pathological role of interleukin 17 in mice subjected to repeated BCG vaccination after infection with Mycobacterium tuberculosis. J. Exp. Med. 207: 1609-1616.
31. Khader, S. A., L. Guglani, J. Rangel-Moreno, R. Gopal, B. A. Junecko, J. J. Fountain, C. Martino, J. E. Pearl, M. Tighe, Y. Y. Lin, et al. 2011. IL-23 is required for long-term control of Mycobacterium tuberculosis and B cell follicle formation in the infected lung. J. Immunol. 187: 5402-5407.
32. Henderson, R. A., S. C. Watkins, and J. L. Flynn. 1997. Activation of human dendritic cells following infection with Mycobacterium tuberculosis. J. Immunol. 159: 635-643. (Pubitemid 127484212)
33. Hanekom, W. A., M. Mendillo, C. Manca, P. A. Haslett, M. R. Siddiqui, C. Barry, III, and G. Kaplan. 2003. Mycobacterium tuberculosis inhibits maturation of human monocyte-derived dendritic cells in vitro. J. Infect. Dis. 188: 257-266. (Pubitemid 36898158)
34. Samten, B., J. C. Townsend, Z. Sever-Chroneos, V. Pasquinelli, P. F. Barnes, and Z. C. Chroneos. 2008. An antibody against the surfactant protein A (SP-A)-binding domain of the SP-A receptor inhibits T cell-mediated immune responses to Mycobacterium tuberculosis. J. Leukoc. Biol. 84: 115-123. (Pubitemid 351960286)
35. Samten, B., P. Ghosh, A. K. Yi, S. E. Weis, D. L. Lakey, R. Gonsky, U. Pendurthi, B. Wizel, Y. Zhang, M. Zhang, et al. 2002. Reduced expression of nuclear cyclic adenosine 5′-monophosphate response element-binding proteins and IFN-γ promoter function in disease due to an intracellular pathogen. J. Immunol. 168: 3520-3526. (Pubitemid 34250420)
36. Samten, B., J. C. Townsend, S. E. Weis, A. Bhoumik, P. Klucar, H. Shams, and P. F. Barnes. 2008. CREB, ATF, and AP-1 transcription factors regulate IFN-γ secretion by human T cells in response to mycobacterial antigen. J. Immunol. 181: 2056-2064.
37. Wolf, A. J., L. Desvignes, B. Linas, N. Banaiee, T. Tamura, K. Takatsu, and J. D. Ernst. 2008. Initiation of the adaptive immune response to Mycobacterium tuberculosis depends on antigen production in the local lymph node, not the lungs. J. Exp. Med. 205: 105-115. (Pubitemid 351185719)
38. Wolf, A. J., B. Linas, G. J. Trevejo-Nuñez, E. Kincaid, T. Tamura, K. Takatsu, and J. D. Ernst. 2007. Mycobacterium tuberculosis infects dendritic cells with high frequency and impairs their function in vivo. J. Immunol. 179: 2509-2519.
39. Balboa, L., M. M. Romero, N. Yokobori, P. Schierloh, L. Geffner, J. I. Basile, R. M. Musella, E. Abbate, S. de la Barrera, M. C. Sasiain, and M. Alemán. 2010. Mycobacterium tuberculosis impairs dendritic cell response by altering CD1b, DC-SIGN and MR profile. Immunol. Cell Biol. 88: 716-726.
40. Tuyaerts, S., J. L. Aerts, J. Corthals, B. Neyns, C. Heirman, K. Breckpot, K. Thielemans, and A. Bonehill. 2007. Current approaches in dendritic cell generation and future implications for cancer immunotherapy. Cancer Immunol. Immunother. 56: 1513-1537. (Pubitemid 47094397)
41. O'Sullivan, B., and R. Thomas. 2003. CD40 and dendritic cell function. Crit. Rev. Immunol. 23: 83-107. (Pubitemid 36875475)
42. Mortellaro, A., L. Robinson, and P. Ricciardi-Castagnoli. 2009. Spotlight on mycobacteria and dendritic cells: will novel targets to fight tuberculosis emerge? EMBO Mol. Med. 1: 19-29.
43. Mishra, B. B., P. Moura-Alves, A. Sonawane, N. Hacohen, G. Griffiths, L. F. Moita, and E. Anes. 2010. Mycobacterium tuberculosis protein ESAT-6 is a potent activator of the NLRP3/ASC inflammasome. Cell. Microbiol. 12: 1046-1063.
44. Launois, P., R. DeLeys, M. N. Niang, A. Drowart, M. Andrien, P. Dierckx, J. L. Cartel, J. L. Sarthou, J. P. Van Vooren, and K. Huygen. 1994. T-cell-epitope mapping of the major secreted mycobacterial antigen Ag85A in tuberculosis and leprosy. Infect. Immun. 62: 3679-3687.
45. Derrick, S. C., and S. L. Morris. 2007. The ESAT6 protein of Mycobacterium tuberculosis induces apoptosis of macrophages by activating caspase expression. Cell. Microbiol. 9: 1547-1555. (Pubitemid 46774025)
46. Kim, S., K. B. Elkon, and X. Ma. 2004. Transcriptional suppression of interleukin-12 gene expression following phagocytosis of apoptotic cells. Immunity 21: 643-653. (Pubitemid 39487888)
47. Spensieri, F., G. Fedele, C. Fazio, M. Nasso, P. Stefanelli, P. Mastrantonio, and C. M. Ausiello. 2006. Bordetella pertussis inhibition of interleukin-12 (IL-12) p70 in human monocyte-derived dendritic cells blocks IL-12 p35 through adenylate cyclase toxin-dependent cyclic AMP induction. Infect. Immun. 74: 2831-2838. (Pubitemid 43672993)
48. Hickey, F. B., C. F. Brereton, and K. H. Mills. 2008. Adenylate cycalse toxin of Bordetella pertussis inhibits TLR-induced IRF-1 and IRF-8 activation and IL-12 production and enhances IL-10 through MAPK activation in dendritic cells. J. Leukoc. Biol. 84: 234-243. (Pubitemid 351960299)
49. Bohnenkamp, H. R., K. T. Papazisis, J. M. Burchell, and J. Taylor-Papadimitriou. 2007. Synergism of Toll-like receptor-induced interleukin-12p70 secretion by monocyte-derived dendritic cells is mediated through p38 MAPK and lowers the threshold of T-helper cell type 1 responses. Cell. Immunol. 247: 72-84. (Pubitemid 350019447)
50. Mäkelä, S. M., M. Strengell, T. E. Pietilä, P. Osterlund, and I. Julkunen. 2009. Multiple signaling pathways contribute to synergistic TLR ligand-dependent cytokine gene expression in human monocyte-derived macrophages and dendritic cells. J. Leukoc. Biol. 85: 664-672.
51. Kobayashi, M., L. Fitz, M. Ryan, R. M. Hewick, S. C. Clark, S. Chan, R. Loudon, F. Sherman, B. Perussia, and G. Trinchieri. 1989. Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. J. Exp. Med. 170: 827-845. (Pubitemid 19226667)
52. Schulz, O., A. D. Edwards, M. Schito, J. Aliberti, S. Manickasingham, A. Sher, and C. Reis e Sousa. 2000. CD40 triggering of heterodimeric IL-12 p70 production by dendritic cells in vivo requires a microbial priming signal. Immunity 13: 453-462.
53. Sender, L. Y., K. Gibbert, Y. Suezer, H. H. Radeke, U. Kalinke, and Z. Waibler. 2010. CD40 ligand-triggered human dendritic cells mount interleukin-23 responses that are further enhanced by danger signals. Mol. Immunol. 47: 1255-1261.
54. Snijders, A., C. M. Hilkens, T. C. van der Pouw Kraan, M. Engel, L. A. Aarden, and M. L. Kapsenberg. 1996. Regulation of bioactive IL-12 production in lipopolysaccharide-stimulated human monocytes is determined by the expression of the p35 subunit. J. Immunol. 156: 1207-1212.
55. Oppmann, B., R. Lesley, B. Blom, J. C. Timans, Y. Xu, B. Hunte, F. Vega, N. Yu, J. Wang, K. Singh, et al. 2000. Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity 13: 715-725.
56. Liu, J., S. Cao, L. M. Herman, and X. Ma. 2003. Differential regulation of interleukin (IL)-12 p35 and p40 gene expression and interferon (IFN)-γ-primed IL-12 production by IFN regulatory factor 1. J. Exp. Med. 198: 1265-1276. (Pubitemid 37323391)
57. Sheikh, S. Z., T. Kobayashi, K. Matsuoka, J. C. Onyiah, and S. E. Plevy. 2011. Characterization of an interferon-stimulated response element (ISRE) in the Il23a promoter. J. Biol. Chem. 286: 1174-1180.
58. Kortylewski, M., H. Xin, M. Kujawski, H. Lee, Y. Liu, T. Harris, C. Drake, D. Pardoll, and H. Yu. 2009. Regulation of the IL-23 and IL-12 balance by Stat3 signaling in the tumor microenvironment. Cancer Cell 15: 114-123.
59. Liu, W., X. Ouyang, J. Yang, J. Liu, Q. Li, Y. Gu, M. Fukata, T. Lin, J. C. He, M. Abreu, et al. 2009. AP-1 activated by Toll-like receptors regulates expression of IL-23 p19. J. Biol. Chem. 284: 24006-24016.
60. McGeachy, M. J., and D. J. Cua. 2008. Th17 cell differentiation: the long and winding road. Immunity 28: 445-453. (Pubitemid 351467042)
61. Wilson, N. J., K. Boniface, J. R. Chan, B. S. McKenzie, W. M. Blumenschein, J. D. Mattson, B. Basham, K. Smith, T. Chen, F. Morel, et al. 2007. Development, cytokine profile and function of human interleukin 17-producing helper T cells. Nat. Immunol. 8: 950-957.
62. H17 lineage. Nature 441: 231-234.
63. H17 and regulatory T cells. Nature 441: 235-238.
64. (H)-17 cells does require TGF-β! Nat. Immunol. 9: 588-590.
65. Bhattacharyya, S., P. Sen, M. Wallet, B. Long, A. S. Baldwin, Jr., and R. Tisch. 2004. Immunoregulation of dendritic cells by IL-10 is mediated through suppression of the PI3K/Akt pathway and of IκB kinase activity. Blood 104: 1100-1109. (Pubitemid 39038031)
66. Loscher, C. E., E. Draper, O. Leavy, D. Kelleher, K. H. Mills, and H. M. Roche. 2005. Conjugated linoleic acid suppresses NF-κB activation and IL-12 production in dendritic cells through ERK-mediated IL-10 induction. J. Immunol. 175: 4990-4998. (Pubitemid 41456381)
67. Pathak, S. K., S. Basu, K. K. Basu, A. Banerjee, S. Pathak, A. Bhattacharyya, T. Kaisho, M. Kundu, and J. Basu. 2007. Direct extracellular interaction between the early secreted antigen ESAT-6 of Mycobacterium tuberculosis and TLR2 inhibits TLR signaling in macrophages. Nat. Immunol. 8: 610-618. (Pubitemid 46785125)
68. Ouaaz, F., J. Arron, Y. Zheng, Y. Choi, and A. A. Beg. 2002. Dendritic cell development and survival require distinct NF-κB subunits. Immunity 16: 257-270. (Pubitemid 34211965)
69. Gabriele, L., and K. Ozato. 2007. The role of the interferon regulatory factor (IRF) family in dendritic cell development and function. Cytokine Growth Factor Rev. 18: 503-510. (Pubitemid 47302829)
70. Pine, R. 2002. IRF and tuberculosis. J. Interferon Cytokine Res. 22: 15-25. (Pubitemid 34161279)
71. Qiao, Y., S. Prabhakar, A. Canova, Y. Hoshino, M. Weiden, and R. Pine. 2004. Posttranscriptional inhibition of gene expression by Mycobacterium tuberculosis offsets transcriptional synergism with IFN-γ and posttranscriptional upregulation by IFN-γ. J. Immunol. 172: 2935-2943. (Pubitemid 38263680)
72. Yamada, H., S. Mizuno, and I. Sugawara. 2002. Interferon regulatory factor 1 in mycobacterial infection. Microbiol. Immunol. 46: 751-760. (Pubitemid 35428951)
73. Cooper, A. M., J. E. Pearl, J. V. Brooks, S. Ehlers, and I. M. Orme. 2000. Expression of the nitric oxide synthase 2 gene is not essential for early control of Mycobacterium tuberculosis in the murine lung. Infect. Immun. 68: 6879-6882. (Pubitemid 32463397)
74. Majlessi, L., P. Brodin, R. Brosch, M. J. Rojas, H. Khun, M. Huerre, S. T. Cole, and C. Leclerc. 2005. Influence of ESAT-6 secretion system 1 (RD1) of Mycobacterium tuberculosis on the interaction between mycobacteria and the host immune system. J. Immunol. 174: 3570-3579. (Pubitemid 40354066)
75. Chatterjee, S., V. P. Dwivedi, Y. Singh, I. Siddiqui, P. Sharma, L. Van Kaer, D. Chattopadhyay, and G. Das. 2011. Early secreted antigen ESAT-6 of Mycobacterium tuberculosis promotes protective T helper 17 cell responses in a tolllike receptor-2-dependent manner. PLoS Pathog. 7: e1002378.